Daniel J. Rader

发表

Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

D. Rader, J. Frohlich, M. Clerc, 1994, The Journal of clinical investigation.

RECENT HIGHLIGHTS OF ATVB

C. Weber, Y. Döring, E. V. D. Vorst, 2019 .

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

E. Rimm, Mingyao Li, M. Reilly, 2009, The Journal of clinical investigation.

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2016, Journal of clinical lipidology.

Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

D. Rader, T. Ishikawa, H. Nakamura, 1993, The Journal of clinical investigation.

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

D. Gaudet, D. Rader, R. Hegele, 2013, The Lancet.

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

D. Rader, J. Hoeg, M. Grossman, 1995, The Journal of clinical investigation.

In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism.

D. Rader, H. Brewer, L. Zech, 1994, Journal of lipid research.

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.

D. Rader, H. Brewer, L. Zech, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

D. Rader, H. Brewer, T. Ishikawa, 1995, The Journal of clinical investigation.

patient-oriented and epidemiological research Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism

D. Rader, E. Schaefer, J. Millar, 2009 .